Investigating how a viral protein affects brain inflammation and damage in HIV patients

Viral Protein R (Vpr) in HIV-associated Brain Neuroinflammation and Neurotoxicity

NIH-funded research Baltimore VA Medical Center · NIH-11061184

This study is looking at how a specific HIV protein might cause brain inflammation and related mental health issues, like depression, in people living with HIV, especially veterans, to find new ways to help improve their well-being.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionBaltimore VA Medical Center NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-11061184 on NIH RePORTER

What this research studies

This research focuses on understanding the role of the HIV-1 viral protein R (Vpr) in causing brain inflammation and damage, particularly in individuals living with HIV. It aims to explore how Vpr contributes to neurocognitive disorders and mental health issues, such as depression and suicide risk, which are prevalent among HIV-infected patients. By examining the mechanisms of neuroinflammation and neurotoxicity, the study seeks to identify potential therapeutic targets that could improve the quality of life for those affected. The research is particularly relevant to veterans, who may experience these complications at higher rates.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals living with HIV who are experiencing neurocognitive disorders or mental health challenges.

Not a fit: Patients who are HIV-negative or those without any neurological complications related to HIV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that alleviate brain inflammation and improve mental health outcomes for HIV patients.

How similar studies have performed: Previous research has indicated that targeting specific viral factors like Vpr may provide new insights into managing HIV-related neurocognitive disorders, suggesting a promising avenue for further exploration.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome VirusAcquired brain injury
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.